FDA

How A Prescription Drug Becomes Available Over the Counter

by Veronica Salib

The FDA approval process is complex and involves multiple steps. Understanding how a prescription drug becomes available over the counter (OTC) is essential for healthcare professionals, members of the pharmaceutical industry, and...

US FDA Accelerated Approval for 48 Non-oncology Drugs

by Veronica Salib

The FDA approval process is multi-faceted and involves several aspects. One of these aspects is accelerated approval, which is meant to approve drugs to treat severe or fatal diseases. According to a...

FDA and NIH Launch Partnership for Rare Neurodegenerative Diseases

by Veronica Salib

Earlier this week, the FDA and NIH announced their launch of a public–private partnership for research on rare neurodegenerative diseases. The partnership, called the Critical Path for Rare...

Amgen’s Immunotherapy for Lung Cancer Reduces Disease Progression by 34%

by Hayden Schmidt

Results from the Phase III CodeBreaK 200 clinical trial found that Amgen’s targeted therapy Lumakras successfully extended progression-free survival (PFS) by about two months and was 15% more...

Medications in the US Are More Widely Available than in Germany

by Veronica Salib

A retrospective cohort study was conducted using data from January 1, 2004, to December 31, 2018. The researchers reviewed information from the FDA and the European Medicines Agency (EMA) to determine...

Paxlovid Advantageous for Elderly COVID-19 Patients, Ineffective in Younger Adults

by Hayden Schmidt

A study published on September 1st in the New England Journal of Medicine tracking health data from 109,254 Israeli adults found a 73% reduction in hospitalization and a 79% reduction in COVID-19...

FDA Announces That 35% of Drug Samples Were Non-Compliant

by Veronica Salib

The FDA’s Report on The State of Pharmaceutical Quality is published annually to analyze quality measures related to drug manufacturers and products. The report looked at manufacturing site...

FDA Approves Bivalent COVID Boosters

by Veronica Salib

As the COVID pandemic progresses and new variants appear, clinicians and public health professionals have been concerned about the level of vaccine protection for new variants and subvariants. To...

FDA Approved the Use of Omnipod 5 for Children Over 2

by Veronica Salib

In January 2022, Omnipod 5 was first approved for anyone over six. Omnipod 5 is the first tubeless automated insulin delivery (AID) made available in the United States for a broad age range. Recently,...

WHO Recommends Use of Monoclonal Antibodies in Ebola Treatment

by Veronica Salib

Ebola virus disease (EVD) is a potentially fatal disease caused by infection with ebolavirus. This WHO statement regards EVD caused by the Zaire ebolavirus. Following a review of many randomized...

FDA Approved AUVELITY for Major Depressive Disorder in Adults

by Veronica Salib

On August 19, 2022, the FDA approved AUVELITY — an oral medication manufactured by Axsome Therapeutics — for the treatment of major depressive disorder (MDD) in adults. This medication...

FDA Approves Mirena for 8 Years

by Veronica Salib

Alongside Kyleena and Liletta, Mirena is one of three hormonal intrauterine devices (IUD) available in the United States. Previously, the duration of use for Mirena was seven years, at which point the...

FDA Expands Emergency Use Authorization for Novavax COVID Vaccine in Kids

by Veronica Salib

As the COVID pandemic progresses and infection rates fluctuate, public health officials and organizations seek to provide more options to protect against illness. On August 19, Novavax announced that...

FDA Approves Cell-Based Gene Therapy for Patients with Beta Thalassemia

by Veronica Salib

On August 17, 2022, the FDA approved bluebird bio's Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy to treat patients with beta thalassemia who need regular red blood...

FDA Approves the Sale of Hearing Aids over the Counter

by Veronica Salib

Recently, the FDA approved the sale of some over-the-counter (OTC) hearing aids, widening access to those who need them. According to the National Institute on Deafness and Other Communication...

FDA Considers Dividing Monkeypox Vaccine Doses

by Veronica Salib

Monkeypox was declared a public health emergency by the WHO on Saturday, July 23, 2022. Since the rise of monkeypox rates, public health organizations have urged at-risk populations to seek...

How Pharmaceutical Patents Contribute to Increased Drug Costs

by Veronica Salib

In the United States, drug prices have soared in recent years. The pharmaceutical industry and medicine, in general, have been criticized for these rising drug costs. Beyond the associated financial burden, inflated medication costs also...

Update on FDA Review and Enforcement of Non-Tobacco Nicotine Products

by Veronica Salib

On April 28, 2022, the FDA placed a total ban on all flavored nicotine products in an attempt to reduce the number of nicotine-related diseases and illnesses. Following previous FDA rulings to ban...

Lyons Magnus Recalls Products due to Microbial Contamination

by Veronica Salib

Lyons Magnus LLC, a part of the food service industry, recently recalled several products due to potential microbial contamination. In the company statement, Cronobacter sakazakii and Clostridium...

HHS Statement on FDA Approval of Bavarian Nordic Monkeypox Vaccine

by Veronica Salib

On Saturday, July 23, 2022, the director-general of the WHO declared monkeypox a public health crisis. Public health organizations have encouraged vaccination for at-risk populations to minimize the...